Greg Engel is CEO at Organigram Inc. in Moncton, New Brunswick, a leading publicly traded licensed producer of medical cannabis in Canada. He has more than 30 years of experience in the pharmaceutical, biotechnology, medical cannabis and consumer packaged goods industries.

Articles by this author

Planning for the future of cannabis in Canada

In February 2016, in Allard v. Canada 2016 FC 236 (Allard), the Federal Court of Canada struck down regulations prohibiting patients from producing their own medical cannabis. Subsequently, the federal government decided not to appeal …

Read More

The case against taxing medical cannabis

In 2015, research funded by the University of British Columbia Institute for Healthy Living and Chronic Disease Prevention found more than half of respondents who use cannabis for medical purposes reported that they can never …

Read More